RATIONALE: Despite a national reduction in the prevalence of cigarette smoking, ~19% of the adult US population persists in this behavior, with the highest prevalence among 18-25-year-olds. Given that the choice to smoke imposes a known health risk, clarification of brain function related to decision-making, particularly involving risk-taking, in smokers may inform prevention and smoking cessation strategies. OBJECTIVES: This study aimed to compare brain function related to decision-making in young smokers and nonsmokers. METHODS: The Balloon Analogue Risk Task (BART) is a computerized risky decision-making task in which participants pump virtual balloons, each pump associated with an incremental increase in potential payoff on a given trial but also with greater risk of balloon explosion and loss of payoff. We used this task to compare brain activation associated with risky decision-making in smokers (n = 18) and nonsmokers (n = 25), while they performed the BART during functional magnetic resonance imaging (fMRI). The participants were young men and women, 17-21 years of age. RESULTS: Risk level (number of pumps) modulated brain activation in the right dorsolateral and ventrolateral prefrontal cortices more in smokers than in nonsmokers, and smoking severity (Heaviness of Smoking Index) was positively related to this modulation in an adjacent frontal region. CONCLUSIONS: Given evidence for involvement of the right dorsolateral and ventrolateral prefrontal cortices in inhibitory control, these findings suggest that young smokers have a different contribution of prefrontal cortical substrates to risky decision-making than nonsmokers. Future studies are warranted to determine whether the observed neurobiological differences precede or result from smoking.
RATIONALE: Despite a national reduction in the prevalence of cigarette smoking, ~19% of the adult US population persists in this behavior, with the highest prevalence among 18-25-year-olds. Given that the choice to smoke imposes a known health risk, clarification of brain function related to decision-making, particularly involving risk-taking, in smokers may inform prevention and smoking cessation strategies. OBJECTIVES: This study aimed to compare brain function related to decision-making in young smokers and nonsmokers. METHODS: The Balloon Analogue Risk Task (BART) is a computerized risky decision-making task in which participants pump virtual balloons, each pump associated with an incremental increase in potential payoff on a given trial but also with greater risk of balloon explosion and loss of payoff. We used this task to compare brain activation associated with risky decision-making in smokers (n = 18) and nonsmokers (n = 25), while they performed the BART during functional magnetic resonance imaging (fMRI). The participants were young men and women, 17-21 years of age. RESULTS: Risk level (number of pumps) modulated brain activation in the right dorsolateral and ventrolateral prefrontal cortices more in smokers than in nonsmokers, and smoking severity (Heaviness of Smoking Index) was positively related to this modulation in an adjacent frontal region. CONCLUSIONS: Given evidence for involvement of the right dorsolateral and ventrolateral prefrontal cortices in inhibitory control, these findings suggest that young smokers have a different contribution of prefrontal cortical substrates to risky decision-making than nonsmokers. Future studies are warranted to determine whether the observed neurobiological differences precede or result from smoking.
Authors: C W Lejuez; Jennifer P Read; Christopher W Kahler; Jerry B Richards; Susan E Ramsey; Gregory L Stuart; David R Strong; Richard A Brown Journal: J Exp Psychol Appl Date: 2002-06
Authors: Adrianna Mendrek; John Monterosso; Sara L Simon; Murray Jarvik; Arthur Brody; Richard Olmstead; Catherine P Domier; Mark S Cohen; Monique Ernst; Edythe D London Journal: Addict Behav Date: 2005-07-11 Impact factor: 3.913
Authors: Marina A Bornovalova; Alex Cashman-Rolls; Jennifer M O'Donnell; Kenneth Ettinger; Jerry B Richards; H deWit; C W Lejuez Journal: Pharmacol Biochem Behav Date: 2008-11-14 Impact factor: 3.533
Authors: Bernhard Hommel; Rico Fischer; Lorenza S Colzato; Wery P M van den Wildenberg; Cristiano Cellini Journal: J Exp Psychol Hum Percept Perform Date: 2011-12-26 Impact factor: 3.332
Authors: Leslie K Jacobsen; W Einar Mencl; R Todd Constable; Michael Westerveld; Kenneth R Pugh Journal: Psychopharmacology (Berl) Date: 2007-05-16 Impact factor: 4.415
Authors: Andréa L Hobkirk; Ryan P Bell; Amanda V Utevsky; Scott Huettel; Christina S Meade Journal: Drug Alcohol Depend Date: 2018-10-24 Impact factor: 4.492
Authors: Ranjita Poudel; Michael C Riedel; Taylor Salo; Jessica S Flannery; Lauren D Hill-Bowen; Simon B Eickhoff; Angela R Laird; Matthew T Sutherland Journal: Drug Alcohol Depend Date: 2020-02-04 Impact factor: 4.492
Authors: Angelica M Morales; Dara Ghahremani; Milky Kohno; Gerhard S Hellemann; Edythe D London Journal: Neuropsychopharmacology Date: 2014-03-03 Impact factor: 7.853
Authors: Yang Qu; Andrew J Fuligni; Adriana Galván; Matthew D Lieberman; Eva H Telzer Journal: Soc Cogn Affect Neurosci Date: 2016-03-24 Impact factor: 3.436
Authors: Dale S Mantey; Maria R Cooper; Stephanie L Clendennen; Keryn E Pasch; Cheryl L Perry Journal: J Adolesc Health Date: 2016-04-12 Impact factor: 5.012
Authors: J David Jentsch; James R Ashenhurst; M Catalina Cervantes; Stephanie M Groman; Alexander S James; Zachary T Pennington Journal: Ann N Y Acad Sci Date: 2014-03-21 Impact factor: 5.691